735 results on '"van Oosterom, A T"'
Search Results
2. Systemic treatment of bladder cancer
3. Vincristin, Bleomycin, Mitomycin-C und Cisplatin als neoadjuvante Therapie bei der Strahlentherapie von Hochrisikopatientinnen mit Plattenepithelkarzinom der Cervix uteri
4. Intra-hepatic Mitomycin C bolus infusion in the treatment of extensive liver metastases of breast cancer
5. A phase II trial of docetaxel (Taxotere®) as second-line chemotherapy in patients with metastatic breast cancer
6. New guidelines to evaluate the response to treatment in solid tumors
7. Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial
8. Pharmacology of Anticancer Drugs in the Elderly Population
9. Metastatic Soft Tissue Sarcoma in Adults: Prognosis and Treatment Options
10. Proteomics in cancer research: Methods and application of array-based protein profiling technologies
11. Intravesical Drug Delivery: Pharmacokinetic and Clinical Considerations
12. Influence of investigator experience and microscopic field size on microvessel density in node-negative breast carcinoma
13. Effects and systemic uptake of the new mitomycin C analogue KW-2149 in beagle dogs after intravesical administration
14. Differential protein expression profile in gastrointestinal stromal tumors
15. Association of enzyme and transporter genotypes with the pharmacokinetics of imatinib
16. Everolimus alters imatinib blood partition in favour of the erythrocyte
17. Clinical and Molecular Studies of the Effect of Imatinib on Advanced Aggressive Fibromatosis (desmoid tumor)
18. The effects of an ACTH (4–9) analogue on development of cisplatin neuropathy in testicular cancer: A randomized trial
19. Abstracts of lectures and posters pharmaceutical and biomedical analysis meeting
20. In vitro and in vivo chemosensitizing effect of cyclosporin A on an intrinsic multidrug-resistant rat colon tumour
21. Drug resistance in rat colon cancer cell lines is associated with minor changes in susceptibility to cytotoxic cells
22. Genetic predisposition to oral absorption of imatinib: correlation of a variant allele in ABCG2 with transport activity.: 296E.
23. Initial and Late Resistance to Imatinib in Advanced Gastrointestinal Stromal Tumors Are Predicted by Different Prognostic Factors: A European Organisation for Research and Treatment of Cancer–Italian Sarcoma Group–Australasian Gastrointestinal Trials Group Study
24. Changing phenotype of gastrointestinal stromal tumours under imatinib mesylate treatment: a potential diagnostic pitfall
25. Randomized Phase II/III Trial of Interferon Alfa-2a With and Without 13-cis-Retinoic Acid in Patients With Progressive Metastatic Renal Cell Carcinoma: The European Organisation for Research and Treatment of Cancer Genito-Urinary Tract Cancer Group (EORTC 30951)
26. Phase I and Pharmacokinetic Study of Oral Irinotecan Given Once Daily for 5 Days Every 3 Weeks in Combination With Capecitabine in Patients With Solid Tumors
27. The relevance of therapeutic drug monitoring in plasma and erythrocytes in anti-cancer drug treatment
28. Phase II study on 9-nitrocamptothecin (RFS 2000) in patients with advanced or metastatic urothelial tract tumors
29. Combination therapy with gefitinib, an epidermal growth factor receptor tyrosine kinase inhibitor, gemcitabine and cisplatin in patients with advanced solid tumors
30. Doxorubicin plus ifosfamide with rhGM-CSF in the treatment of advanced adult soft-tissue sarcomas: preliminary results of a phase II study from the EORTC Soft-Tissue and Bone Sarcoma Group
31. Scientific Proceedings Second International Symposium on Cytostatic Drug Resistance
32. Real-time quantitative RT–PCR and detection of tumour cell dissemination in breast cancer patients: plasmid versus cell line dilutions
33. Impact of anti-angiogenic therapy (AAT) on the intratumoral delivery of CPT-11 in a colorectal cancer tumor model
34. Population pharmacokinetic and dynamic analysis of the topoisomerase I inhibitor lurtotecan in phase II studies
35. Randomized Phase III Trial of High-Dose-Intensity Methotrexate, Vinblastine, Doxorubicin, and Cisplatin (MVAC) Chemotherapy and Recombinant Human Granulocyte Colony-Stimulating Factor Versus Classic MVAC in Advanced Urothelial Tract Tumors: European Organization for Research and Treatment of Cancer Protocol No. 30924
36. A real-time quantitative reverse transcriptase polymerase chain reaction (RT-PCR) to detect breast carcinoma cells in peripheral blood
37. Quantification of the anticancer agent STI-571 in erythrocytes and plasma by measurement of sediment technology and liquid chromatography–tandem mass spectrometry
38. New Guidelines to Evaluate the Response to Treatment in Solid Tumors
39. Weekly docetaxel in aged or frail metastatic breast cancer patients: Toxicity profile and activity.
40. Dacarbazine, cisplatin and IFN-α with or without IL-2 in advanced melanoma (EORTC trial 18951).
41. Pharmacokinetics and bioavailability of oral 5′-deoxy-5-fluorouridine in cancer patients
42. Deep cerebral invasion by basal cell carcinoma of the scalp
43. Angiogenesis: possibilities for therapeutic interventions
44. Update of phase I study of imatinib (STI571) in advanced soft tissue sarcomas and gastrointestinal stromal tumors: a report of the EORTC Soft Tissue and Bone Sarcoma Group
45. Comparison of Daunorubicin and Fluo-3 for Detection of Multidrug Resistance in Human Tumor Cells
46. Ultraradical debulking of epithelial ovarian cancer with the ultrasonic surgical aspirator: A prospective randomized trial
47. Diagnosis and treatment of soft tissue sarcomas in adults
48. Immunohistochemical study of topoisomerase II-alpha expression in primary ductal carcinoma of the breast
49. Pulmonary toxicity and bleomycin
50. Diagnosis and treatment of soft tissue sarcomas in adults
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.